These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration. Lodi R; Setola E; Tonon C; Ambrosetto P; Franceschi E; Crinò L; Barbiroli B; Cortelli P Magn Reson Imaging; 2003 Nov; 21(9):1003-7. PubMed ID: 14684203 [TBL] [Abstract][Full Text] [Related]
9. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843 [TBL] [Abstract][Full Text] [Related]
10. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Wick W; Platten M; Meisner C; Felsberg J; Tabatabai G; Simon M; Nikkhah G; Papsdorf K; Steinbach JP; Sabel M; Combs SE; Vesper J; Braun C; Meixensberger J; Ketter R; Mayer-Steinacker R; Reifenberger G; Weller M; Lancet Oncol; 2012 Jul; 13(7):707-15. PubMed ID: 22578793 [TBL] [Abstract][Full Text] [Related]
11. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas. Sipos L; Vitanovics D; Afra D Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767 [TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors. Combs SE; Nagy M; Edler L; Rausch R; Bischof M; Welzel T; Debus J; Schulz-Ertner D Radiother Oncol; 2008 Aug; 88(2):177-82. PubMed ID: 18395280 [TBL] [Abstract][Full Text] [Related]
14. Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? Siker ML; Chakravarti A; Mehta MP Crit Rev Oncol Hematol; 2006 Nov; 60(2):99-111. PubMed ID: 17027279 [TBL] [Abstract][Full Text] [Related]
15. Temozolomide in glioblastoma multiforme of the elderly. Brandes AA; Vastola F; Basso U; Pasetto LM; Ermani M; Berti F; Rotilio A; Amistà P; Scienza R; Monfardini S Tumori; 2002; 88(1 Suppl 1):S69-70. PubMed ID: 11989929 [No Abstract] [Full Text] [Related]
16. Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy. Chinot OL; Honore S; Dufour H; Barrie M; Figarella-Branger D; Muracciole X; Braguer D; Martin PM; Grisoli F J Clin Oncol; 2001 May; 19(9):2449-55. PubMed ID: 11331324 [TBL] [Abstract][Full Text] [Related]
17. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ; Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895 [TBL] [Abstract][Full Text] [Related]
18. Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis. Carroll KT; Hirshman B; Ali MA; Alattar AA; Brandel MG; Lochte B; Lanman T; Carter B; Chen CC World Neurosurg; 2017 Jul; 103():186-193. PubMed ID: 28366748 [TBL] [Abstract][Full Text] [Related]
19. NICE verdict on Temozolomide: where next? Brada M Br J Cancer; 2002 Feb; 86(4):499-500. PubMed ID: 11870526 [No Abstract] [Full Text] [Related]
20. Gliomatosis cerebri treatment in 11 elderly patients. Piccirilli M; Landi A; Salvati M J Exp Clin Cancer Res; 2006 Jun; 25(2):183-7. PubMed ID: 16918128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]